Neurogenic bladder

Jump to: navigation, search
Neurogenic bladder
ICD-10 N31.9
ICD-9 596.54
DiseasesDB 30837
MeSH D001750

WikiDoc Resources for Neurogenic bladder


Most recent articles on Neurogenic bladder

Most cited articles on Neurogenic bladder

Review articles on Neurogenic bladder

Articles on Neurogenic bladder in N Eng J Med, Lancet, BMJ


Powerpoint slides on Neurogenic bladder

Images of Neurogenic bladder

Photos of Neurogenic bladder

Podcasts & MP3s on Neurogenic bladder

Videos on Neurogenic bladder

Evidence Based Medicine

Cochrane Collaboration on Neurogenic bladder

Bandolier on Neurogenic bladder

TRIP on Neurogenic bladder

Clinical Trials

Ongoing Trials on Neurogenic bladder at Clinical

Trial results on Neurogenic bladder

Clinical Trials on Neurogenic bladder at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Neurogenic bladder

NICE Guidance on Neurogenic bladder


FDA on Neurogenic bladder

CDC on Neurogenic bladder


Books on Neurogenic bladder


Neurogenic bladder in the news

Be alerted to news on Neurogenic bladder

News trends on Neurogenic bladder


Blogs on Neurogenic bladder


Definitions of Neurogenic bladder

Patient Resources / Community

Patient resources on Neurogenic bladder

Discussion groups on Neurogenic bladder

Patient Handouts on Neurogenic bladder

Directions to Hospitals Treating Neurogenic bladder

Risk calculators and risk factors for Neurogenic bladder

Healthcare Provider Resources

Symptoms of Neurogenic bladder

Causes & Risk Factors for Neurogenic bladder

Diagnostic studies for Neurogenic bladder

Treatment of Neurogenic bladder

Continuing Medical Education (CME)

CME Programs on Neurogenic bladder


Neurogenic bladder en Espanol

Neurogenic bladder en Francais


Neurogenic bladder in the Marketplace

Patents on Neurogenic bladder

Experimental / Informatics

List of terms related to Neurogenic bladder

For patient information page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Neurogenic bladder refers to dysfunction of the urinary bladder due to disease of the central nervous system or peripheral nerves involved in the control of micturition.


Neurogenic bladder is often associated with spinal cord diseases, injuries, and neural tube defects including spina bifida. It may also be caused by brain tumors and other diseases of the brain, and by peripheral nerve diseases. It is a common complication of major surgery in the pelvis, such as for removal of sacrococcygeal teratoma and other tumors.



Neurogenic bladder usually causes difficulty or full inability to pass urine without use of a catheter or other method. Consequently most treatments involve creation of a stoma that is continent and readily accepts a catheter. These are known as Mitrofanoff mechanisms. Anticholinergic medication may also be used.

Function of the stoma may be augmented by periodic injections of botulinum toxin to relax one of the two sphincters involved in normal urination.[1] The effect is longer lasting with botulinum toxin type A than with type B.[2] This use of botulinum toxin is discussed at length in the French medical literature.[3][4][5][6][7]


  1. Akbar M, Abel R, Seyler TM, Gerner HJ, Möhring K (2007). "Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction". BJU Int. 100 (3): 639–45. doi:10.1111/j.1464-410X.2007.06977.x. PMID 17532858.
  2. Hirst GR, Watkins AJ, Guerrero K, Wareham K, Emery SJ, Jones DR, Lucas MG (2007). "Botulinum toxin B is not an effective treatment of refractory overactive bladder". Urology. 69 (1): 69–73. doi:10.1016/j.urology.2006.09.005. PMID 17270619.
  3. Game X, Karsenty G, Chartier-Kastler E, Ruffion A (2007). "[Treatment of neurogenic detrusor hyperactivity: enterocystoplasty]". Prog. Urol. (in French). 17 (3): 584–96. PMID 17622095.
  4. Karsenty G, Corcos J, Schurch B, Ruffion A, Chartier-Kastler E (2007). "[Pharmacological treatment of neurogenic detrusor hyperactivity: intradetrusor botulinum toxin A injections]". Prog. Urol. (in French). 17 (3): 568–75. PMID 17622092.
  5. Chartier-Kastler E, Ruffion A (2007). "[Treatment of vesicoureteric reflux and neurogenic bladder]". Prog. Urol. (in French). 17 (3): 470–2. PMID 17622079.
  6. Chartier-Kastler E, Comperat E, Ruffion A (2007). "[Disorders of bladder compliance and neurogenic bladder]". Prog. Urol. (in French). 17 (3): 442–7. PMID 17622074.
  7. Chenet A, Perrouin-Verbe B, Le Normand L, Labat JJ, Brunel P, Lefort M, Mathé JF (2007). "[Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity.]". doi:10.1016/j.annrmp.2007.03.019. PMID 17490775.